← Every fund

ProShares Ultra Nasdaq Biotechnology

Filed by ProShares Trust. What this fund reported holding in its latest quarterly NPORT-P. Positions are ordered by share of the fund rather than by size, because that is what separates a conviction from a rounding error.

Positions
66
matched to a ticker
Fund size
$103.1M
the filing's own figure
Matched value
$37.1M
of the positions below
As of
2026-08-31
S000018718

What it holds

Largest share of the fund first.

Company% of fundValue
AMGNAmgen Inc4.72%$4.8M
VRTXVertex Pharmaceuticals Inc4.50%$4.6M
GILDGilead Sciences, Inc4.02%$4.1M
REGNRegeneron Pharmaceuticals Inc2.90%$2.9M
MRNAModerna Inc1.96%$2M
ILMNIllumina Inc1.14%$1.2M
ALNYAlnylam Pharmaceuticals Inc1.13%$1.1M
BIIBBiogen Inc1.13%$1.1M
ARGXargenx SE1.01%$1M
INSMInsmed Inc0.93%$944K
INCYIncyte Corp0.87%$879.9K
UTHRUnited Therapeutics Corp0.76%$774.2K
GHGuardant Health Inc0.74%$753.8K
VTRSViatris Inc0.68%$687.2K
MEDPMedpace Holdings Inc0.60%$604.7K
NBIXNeurocrine Biosciences Inc0.55%$553.7K
BBIOBridgeBio Pharma Inc0.53%$536K
EXELExelixis Inc0.48%$490.9K
HALOHalozyme Therapeutics Inc0.45%$451.3K
BMRNBioMarin Pharmaceutical Inc0.44%$450.5K
MDGLMadrigal Pharmaceuticals Inc0.44%$445.5K
BNTXBiontech SE0.42%$422.3K
ARWRArrowhead Pharmaceuticals Inc0.41%$414.6K
TEMTempus AI Inc0.39%$393.1K
KRYSKrystal Biotech Inc0.37%$379.5K
SNYSanofi SA0.36%$368.9K
AXSMAxsome Therapeutics Inc0.36%$364.9K
IONSIonis Pharmaceuticals Inc0.35%$356.4K
PRAXPraxis Precision Medicines Inc0.35%$349.9K
CYTKCytokinetics Inc0.34%$343.7K
PCVXVaxcyte Inc0.31%$313.4K
TWSTTwist Bioscience Corp0.31%$309.3K
IBRXImmunitybio Inc0.29%$297.6K
COGTCogent Biosciences Inc0.21%$213.8K
LGNDLigand Pharmaceuticals Inc0.20%$204K
ACADACADIA Pharmaceuticals Inc0.17%$176.9K
RLAYRelay Therapeutics Inc0.14%$140.9K
AMLXAmylyx Pharmaceuticals Inc0.13%$134.2K
GPCRStructure Therapeutics Inc0.13%$128K
VCYTVeracyte Inc0.12%$123.3K
ARQTArcutis Biotherapeutics Inc0.11%$107.2K
SUPNSupernus Pharmaceuticals Inc0.09%$91.8K
GMABGenmab A/S0.09%$89.9K
RAREUltragenyx Pharmaceutical Inc0.09%$88.7K
BCRXBioCryst Pharmaceuticals Inc0.09%$88.1K
KODKodiak Sciences Inc0.08%$83.5K
SRPTSarepta Therapeutics Inc0.08%$79.3K
AGIOAgios Pharmaceuticals Inc0.07%$71.6K
CMPSCompass Pathways PLC0.06%$64.3K
NTLAIntellia Therapeutics Inc0.06%$63.5K
FTREFortrea Holdings Inc0.06%$62.1K
NVAXNovavax Inc0.05%$55.1K
INVAInnoviva Inc0.05%$54.7K
MRVIMaravai LifeSciences Holdings Inc0.04%$40.3K
KURAKura Oncology Inc0.04%$40.2K
PCRXPacira Biosciences Inc0.04%$36.4K
CSTLCastle Biosciences Inc0.04%$35.9K
GRFSGrifols SA0.03%$33.7K
TECXTectonic Therapeutic, Inc. - Common Stock0.02%$20.3K
EDITEditas Medicine Inc0.02%$16.8K
PBYIPuma Biotechnology Inc0.02%$16.6K
AVIRAtea Pharmaceuticals, Inc. - common stock0.02%$15.3K
ENTAEnanta Pharmaceuticals Inc0.01%$13.9K
AVXLAnavex Life Sciences Corp0.01%$9.3K
CHRSCoherus Oncology Inc0.01%$7.4K
HUMAHumacyte Inc0.00%$4.8K

Source: NPORT-P filings, via EDGAR. Positions arrive by CUSIP, and only a CUSIP verified against a ticker is kept — so this is what we could match, not everything the fund holds, and the matched value is therefore below the fund's own size. A balance is shares where the filing says `NS` and a principal amount where it says `PA`, which is why it is not labelled shares in both cases.

Follow ProShares Ultra Nasdaq Biotechnology by email

ProShares Ultra Nasdaq Biotechnology's new holdings reports, with the rest of the week's filings. One email a week, free.

Unsubscribe with one click from any email.

Related datasets